JP2024150445A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024150445A5 JP2024150445A5 JP2024099523A JP2024099523A JP2024150445A5 JP 2024150445 A5 JP2024150445 A5 JP 2024150445A5 JP 2024099523 A JP2024099523 A JP 2024099523A JP 2024099523 A JP2024099523 A JP 2024099523A JP 2024150445 A5 JP2024150445 A5 JP 2024150445A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding protein
- seq
- pharmaceutical composition
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762560143P | 2017-09-18 | 2017-09-18 | |
| US62/560,143 | 2017-09-18 | ||
| PCT/US2018/051610 WO2019056023A2 (en) | 2017-09-18 | 2018-09-18 | ANTIBODIES AGAINST CLAUDIN 6 AND METHODS OF TREATING CANCER |
| JP2020515692A JP7599332B2 (ja) | 2017-09-18 | 2018-09-18 | クローディン６抗体及びがんを治療するための方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515692A Division JP7599332B2 (ja) | 2017-09-18 | 2018-09-18 | クローディン６抗体及びがんを治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024150445A JP2024150445A (ja) | 2024-10-23 |
| JP2024150445A5 true JP2024150445A5 (enExample) | 2026-02-06 |
| JP7869831B2 JP7869831B2 (ja) | 2026-06-03 |
Family
ID=65723110
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515692A Active JP7599332B2 (ja) | 2017-09-18 | 2018-09-18 | クローディン６抗体及びがんを治療するための方法 |
| JP2024099523A Active JP7869831B2 (ja) | 2017-09-18 | 2024-06-20 | クローディン６抗体及びがんを治療するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515692A Active JP7599332B2 (ja) | 2017-09-18 | 2018-09-18 | クローディン６抗体及びがんを治療するための方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US20200291111A1 (enExample) |
| EP (2) | EP3826667B1 (enExample) |
| JP (2) | JP7599332B2 (enExample) |
| KR (2) | KR102793719B1 (enExample) |
| CN (2) | CN111565744B (enExample) |
| AU (2) | AU2018334434B2 (enExample) |
| BR (1) | BR112020005196A2 (enExample) |
| CA (1) | CA3076207A1 (enExample) |
| CZ (1) | CZ2021138A3 (enExample) |
| DK (1) | DK3826667T3 (enExample) |
| ES (1) | ES2986343T3 (enExample) |
| FI (1) | FI3826667T3 (enExample) |
| GB (1) | GB202103867D0 (enExample) |
| HU (1) | HUE067603T2 (enExample) |
| IL (2) | IL313238A (enExample) |
| MX (2) | MX428953B (enExample) |
| NO (1) | NO20210351A1 (enExample) |
| PL (1) | PL3826667T3 (enExample) |
| PT (1) | PT3826667T (enExample) |
| SG (1) | SG11202002114RA (enExample) |
| SI (1) | SI3826667T1 (enExample) |
| WO (1) | WO2019056023A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202002114RA (en) * | 2017-09-18 | 2020-04-29 | Univ California | Claudin6 antibodies and methods of treating cancer |
| CA3177215C (en) | 2017-09-29 | 2026-06-09 | Daiichi Sankyo Company, Limited | Antibody-pyrrolobenzodiazepine derivative conjugate |
| KR102063341B1 (ko) * | 2018-12-31 | 2020-01-07 | 다이노나(주) | Icam-1에 특이적으로 결합하는 항체 및 그의 용도 |
| CN119708241A (zh) | 2019-02-15 | 2025-03-28 | 因特格尔莫来库乐有限公司 | 密封蛋白6抗体及其用途 |
| DK3941946T3 (da) * | 2019-03-20 | 2025-03-24 | Univ California | Claudin-6-antistoffer og lægemiddelkonjugater |
| WO2020191344A1 (en) * | 2019-03-20 | 2020-09-24 | The Regents Of The University Of California | Claudin-6 bispecific antibodies |
| US11834512B2 (en) | 2020-05-04 | 2023-12-05 | The Regents Of The University Of California | Inhibiting anti-ENPP1 antibodies |
| CN112386687B (zh) * | 2020-12-09 | 2021-05-04 | 爱龄医美国际健康咨询服务(北京)有限公司 | 一种干细胞外泌体及其在药品和化妆品中的应用 |
| WO2023091512A2 (en) * | 2021-11-16 | 2023-05-25 | Allakos, Inc. | Antibodies to anti-siglec-9 and multispecific antibodies targeting siglec-7 and siglec-9 |
| AU2023219174A1 (en) * | 2022-02-09 | 2024-08-15 | Sera Prognostics, Inc. | Shbg and ibp4 antibodies and methods using same |
| CN120282987A (zh) | 2022-11-30 | 2025-07-08 | 因特格尔莫来库乐有限公司 | 包括双特异性型式的针对紧密连接蛋白6的抗体 |
| KR20260015262A (ko) | 2023-05-25 | 2026-02-02 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 암 치료를 위한 클라우딘-6 접합체의 투여량 |
| JPWO2025075127A1 (enExample) * | 2023-10-04 | 2025-04-10 | ||
| TW202542202A (zh) * | 2024-01-04 | 2025-11-01 | 美商翰森生物有限責任公司 | 抗體、抗原結合片段及其醫療用途 |
| AU2025213885A1 (en) * | 2024-02-01 | 2026-07-16 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Anti-cldn6 antibody, antibody-drug conjugate thereof, and medical use thereof |
| WO2026084392A1 (ko) * | 2024-10-14 | 2026-04-23 | 에이비엘바이오 주식회사 | 항-클라우딘6 항체 및 이의 용도 |
| KR102953072B1 (ko) * | 2025-08-20 | 2026-04-16 | 주식회사 누리사이언스 | 난소 및 난자의 성숙 및/또는 발달을 위한 조성물 및 이의 용도 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4450150A (en) | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
| US4526988A (en) | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| DE3587500T2 (de) | 1984-12-04 | 1993-12-16 | Lilly Co Eli | Tumorbehandlung bei Säugetieren. |
| WO1999040942A1 (en) | 1998-02-10 | 1999-08-19 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
| JP2003530297A (ja) | 1998-10-16 | 2003-10-14 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， リプリゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Ｖｉｐアンタゴニストを用いる併用療法 |
| GB2344287A (en) | 1998-12-03 | 2000-06-07 | Ferring Bv | Controlled release pharmaceutical formulation |
| WO2001058479A1 (en) | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| WO2004033036A2 (en) | 2002-10-04 | 2004-04-22 | Microchips, Inc. | Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
| CA2672581A1 (en) * | 2006-12-14 | 2008-06-19 | Forerunner Pharma Research Co., Ltd. | Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| WO2008130158A1 (en) | 2007-04-19 | 2008-10-30 | Dong-A Pharmaceutical. Co., Ltd | A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| AU2009203464A1 (en) * | 2008-01-11 | 2009-07-16 | Forerunner Pharma Research Co., Ltd. | Anti-CLDN6 antibody |
| EP2404936A1 (en) * | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Cancer therapy using CLDN6 target-directed antibodies in vivo |
| EP3026064B1 (en) * | 2011-05-13 | 2018-10-17 | Ganymed Pharmaceuticals GmbH | Antibodies for treatment of cancer expressing claudin 6 |
| WO2015014376A1 (en) * | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnosis and therapy of cancer involving cancer stem cells |
| AU2014346792A1 (en) * | 2013-11-06 | 2016-06-02 | Abbvie Stemcentrx Llc | Novel anti-claudin antibodies and methods of use |
| CN106459165B (zh) * | 2014-04-01 | 2021-04-20 | 拜恩科技细胞&基因治疗有限公司 | 密封蛋白-6特异性免疫受体和t细胞表位 |
| SG11202002114RA (en) * | 2017-09-18 | 2020-04-29 | Univ California | Claudin6 antibodies and methods of treating cancer |
-
2018
- 2018-09-18 SG SG11202002114RA patent/SG11202002114RA/en unknown
- 2018-09-18 JP JP2020515692A patent/JP7599332B2/ja active Active
- 2018-09-18 FI FIEP18857242.4T patent/FI3826667T3/fi active
- 2018-09-18 CN CN201880073220.3A patent/CN111565744B/zh active Active
- 2018-09-18 ES ES18857242T patent/ES2986343T3/es active Active
- 2018-09-18 EP EP18857242.4A patent/EP3826667B1/en active Active
- 2018-09-18 DK DK18857242.4T patent/DK3826667T3/da active
- 2018-09-18 IL IL313238A patent/IL313238A/en unknown
- 2018-09-18 GB GBGB2103867.4A patent/GB202103867D0/en active Pending
- 2018-09-18 CN CN202410853420.8A patent/CN118667021A/zh active Pending
- 2018-09-18 IL IL273196A patent/IL273196B2/en unknown
- 2018-09-18 HU HUE18857242A patent/HUE067603T2/hu unknown
- 2018-09-18 KR KR1020207009742A patent/KR102793719B1/ko active Active
- 2018-09-18 PL PL18857242.4T patent/PL3826667T3/pl unknown
- 2018-09-18 SI SI201831128T patent/SI3826667T1/sl unknown
- 2018-09-18 CA CA3076207A patent/CA3076207A1/en active Pending
- 2018-09-18 MX MX2020002921A patent/MX428953B/es unknown
- 2018-09-18 US US16/648,428 patent/US20200291111A1/en not_active Abandoned
- 2018-09-18 BR BR112020005196-9A patent/BR112020005196A2/pt active Search and Examination
- 2018-09-18 KR KR1020257011014A patent/KR20250050137A/ko active Pending
- 2018-09-18 EP EP24169481.9A patent/EP4435009A3/en active Pending
- 2018-09-18 AU AU2018334434A patent/AU2018334434B2/en active Active
- 2018-09-18 NO NO20210351A patent/NO20210351A1/en not_active Application Discontinuation
- 2018-09-18 PT PT188572424T patent/PT3826667T/pt unknown
- 2018-09-18 WO PCT/US2018/051610 patent/WO2019056023A2/en not_active Ceased
-
2020
- 2020-03-17 MX MX2025012685A patent/MX2025012685A/es unknown
-
2021
- 2021-03-19 CZ CZ2021138A patent/CZ2021138A3/cs unknown
-
2022
- 2022-04-13 US US17/719,609 patent/US20220372134A1/en not_active Abandoned
-
2023
- 2023-12-19 US US18/545,890 patent/US20240400674A1/en not_active Abandoned
-
2024
- 2024-06-20 JP JP2024099523A patent/JP7869831B2/ja active Active
-
2025
- 2025-01-23 AU AU2025200467A patent/AU2025200467A1/en active Pending
- 2025-06-27 US US19/252,512 patent/US20250333501A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023051986A (ja) | Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体 | |
| JP7784511B2 (ja) | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 | |
| CN109320612B (zh) | 抗her2抗体及其缀合物 | |
| JP2003525061A5 (enExample) | ||
| WO2023025243A1 (zh) | 抗Nectin-4抗体、药物缀合物及其制备方法和用途 | |
| CN107735093A (zh) | Cd123抗体和其结合物 | |
| JP2024501894A5 (enExample) | ||
| WO2024163630A2 (en) | Anti-cdh17 antibodies and use of the same | |
| CN111655290A (zh) | 抗组织因子抗体-药物偶联物及其在癌症治疗中的应用 | |
| JP2023516195A (ja) | Ｃ１９ ｃ３８二特異性抗体 | |
| JP2023536631A5 (enExample) | ||
| JP2024537323A5 (enExample) | ||
| US11110179B2 (en) | Combination of CD33 antibody drug conjugates with chemotherapeutic agents | |
| US20180296691A1 (en) | Anti-efna4 antibody-drug conjugates | |
| WO2023065594A1 (zh) | 抗cd47-cldn18.2双特异性抗体及其用途 | |
| CN112996540B (zh) | 一种c-Met ADC在制备治疗c-Met激酶抑制剂耐药的疾病的药物中的用途 | |
| JP2022530063A (ja) | 抗体製剤 | |
| US20250092152A1 (en) | Humanized antibody capable of binding to heg1 protein | |
| CN120077073A (zh) | 用于治疗里希特氏综合征的针对cd3和cd20的双特异性抗体 | |
| CN120695174A (zh) | 抗人vegf抗体与化药联用在制备治疗卵巢癌的药物中的应用 | |
| JP2022535276A5 (enExample) | ||
| JP2023536630A5 (enExample) | ||
| TWI922217B (zh) | 用於治療類風濕性關節炎的抗體及其用途 | |
| JP7815590B2 (ja) | ビメンチンを発現する腫瘍を治療するためのキットおよび容器 | |
| CN120435319A (zh) | 抗-avb6抗体和抗体-药物缀合物及其在癌症治疗中的用途 |